Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP20 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | CST1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
mRNA | YIPF4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | ASPA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | APOE | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | NCF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | PSMB10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | CDIPT | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | APOD | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ABCC9 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |